Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders.

Journal of neuroimmunology - 15 Mar 2020

Akaishi Tetsuya, Takahashi Toshiyuki, Himori Noriko, Fujihara Kazuo, Misu Tatsuro, Abe Michiaki, Ishii Tadashi, Nakazawa Toru, Aoki Masashi, Nakashima Ichiro

Abstract excerpt

We aimed in this study to elucidate the impact of serum AQP4-IgG titer before starting treatments to the clinical manifestation of neuromyelitis optica spectrum disorders (NMOSD). Serum titer at the onset, measured using live cell-based assay method, did not correlate to the subsequent relapse rate or neurological prognosis. Patients with optic neuritis as the first attack showed significantly higher serum titer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aquaporin 4
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoantigens

Share to Immunoglobulin G

Share to Neuromyelitis Optica

Share to Phenotype

Source

Identifiers

PMID: 31986374
DOI: 10.1016/j.jneuroim.2020.577168

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders.PMID 31986374Read ↗

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.Semantic proximity Read ↗

Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).Semantic proximity Read ↗

The Temporal Dynamics of Pathological Profile and Functional Impairment in Neuromyelitis Optica Spectrum Disorders associated Optic NeuritisSemantic proximity Read ↗

Beyond MOG and AQP4 Antibodies: Alternative Causes of Optic NeuritisSemantic proximity Read ↗

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.Semantic proximity Read ↗

Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.Semantic proximity Read ↗

Clinical characteristics of optic neuritis phenotypes in a 3-year follow-up Chinese cohort.Semantic proximity Read ↗

The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia.Semantic proximity Read ↗

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.Semantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.Semantic proximity Read ↗

Myelitis-Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late-Onset Neuromyelitis Optica Spectrum Disorders.Semantic proximity Read ↗

NMO‐IgG: A Specific Biomarker for Neuromyelitis OpticaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.